Summit Therapeutics Inc. of Miami, FL, a company, filed a Form D exempt-offering notice with the SEC on 2014-03-04. The offering totals $11.6M, of which $11.6M was reported sold. Industry: Biotechnology.
Showing 25 of 34 people.
| Name | Role | Location |
|---|---|---|
| Stephen Davies | Director | Abingdon, X0 |
| Jim Mellon | Director | Lauderhill, FL |
| Barry Price | Director | Abingdon, X0 |
| Raymond Spencer | Executive Officer | Ann Arbor, MI |
| Jeff Huber | Director | San Francisco, CA |
| David Roblin | Executive Officer | Miami Beach, FL |
| Robert Duggan | Director | Grand Cayman, E9 |
| Robert Duggan | Executive Officer | Grand Cayman, E9 |
| Mostafa Ronaghi | Director | Foster City, CA |
| Manmeet Soni | Director | Miami, FL |
| Manmeet Soni | Executive Officer | Miami, FL |
| Mahkam Zanganeh | Director | Miami, FL |
| Mahkam Zanganeh | Executive Officer | Miami, FL |
| Alessandra Cesano | Director | Miami, FL |
| Kenneth Clark | Director | Miami, FL |
| Yu Xia | Director | Miami, FL |
| Robert Booth | Director | Miami, FL |
| Ujwala Mahatme | Director | Miami, FL |
| Leopoldo Zambeletti | Director | COVINA, CA |
| David Wurzer | Director | Mystic, CT |
| Rainer Erdtmann | Director | El Cerrito, CA |
| Michael Paul Donaldson | Executive Officer | Cambridge, MA |
| Houbiers Paul Jos | Executive Officer | Cambridge, MA |
| David Johnathan Powell | Executive Officer | Cambridge, MA |
| Camilla Johnathan Graham | Executive Officer | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-09-26 | D | $235.0M | $235.0M |
| 2024-06-18 | D | $200.0M | $200.0M |
| 2020-11-23 | D | $50.0M | $50.0M |
| 2020-01-02 | D | $47.4M | $47.4M |
| 2019-01-18 | D | $25.0M | $25.0M |